A citation-based method for searching scientific literature

Pamela M Odorizzi, E John Wherry. J Immunol 2012
Times Cited: 118







List of co-cited articles
1092 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection.
Shawn D Blackburn, Haina Shin, W Nicholas Haining, Tao Zou, Creg J Workman, Antonio Polley, Michael R Betts, Gordon J Freeman, Dario A A Vignali, E John Wherry. Nat Immunol 2009
40

T cell exhaustion.
E John Wherry. Nat Immunol 2011
35

Molecular signature of CD8+ T cell exhaustion during chronic viral infection.
E John Wherry, Sang-Jun Ha, Susan M Kaech, W Nicholas Haining, Surojit Sarkar, Vandana Kalia, Shruti Subramaniam, Joseph N Blattman, Daniel L Barber, Rafi Ahmed. Immunity 2007
31

Restoring function in exhausted CD8 T cells during chronic viral infection.
Daniel L Barber, E John Wherry, David Masopust, Baogong Zhu, James P Allison, Arlene H Sharpe, Gordon J Freeman, Rafi Ahmed. Nature 2006
31

Molecular and cellular insights into T cell exhaustion.
E John Wherry, Makoto Kurachi. Nat Rev Immunol 2015
29

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression.
Cheryl L Day, Daniel E Kaufmann, Photini Kiepiela, Julia A Brown, Eshia S Moodley, Sharon Reddy, Elizabeth W Mackey, Joseph D Miller, Alasdair J Leslie, Chantal DePierres,[...]. Nature 2006
25


Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection.
Michael A Paley, Daniela C Kroy, Pamela M Odorizzi, Jonathan B Johnnidis, Douglas V Dolfi, Burton E Barnett, Elizabeth K Bikoff, Elizabeth J Robertson, Georg M Lauer, Steven L Reiner,[...]. Science 2012
559
22

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.
Suzanne L Topalian, F Stephen Hodi, Julie R Brahmer, Scott N Gettinger, David C Smith, David F McDermott, John D Powderly, Richard D Carvajal, Jeffrey A Sosman, Michael B Atkins,[...]. N Engl J Med 2012
20

Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection.
Hyun-Tak Jin, Ana C Anderson, Wendy G Tan, Erin E West, Sang-Jun Ha, Koichi Araki, Gordon J Freeman, Vijay K Kuchroo, Rafi Ahmed. Proc Natl Acad Sci U S A 2010
537
20

Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity.
Kaori Sakuishi, Lionel Apetoh, Jenna M Sullivan, Bruce R Blazar, Vijay K Kuchroo, Ana C Anderson. J Exp Med 2010
18

Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment.
E John Wherry, Joseph N Blattman, Kaja Murali-Krishna, Robbert van der Most, Rafi Ahmed. J Virol 2003
18

Viral immune evasion due to persistence of activated T cells without effector function.
A J Zajac, J N Blattman, K Murali-Krishna, D J Sourdive, M Suresh, J D Altman, R Ahmed. J Exp Med 1998
18

Network analysis reveals centrally connected genes and pathways involved in CD8+ T cell exhaustion versus memory.
Travis A Doering, Alison Crawford, Jill M Angelosanto, Michael A Paley, Carly G Ziegler, E John Wherry. Immunity 2012
333
16

Nivolumab plus ipilimumab in advanced melanoma.
Jedd D Wolchok, Harriet Kluger, Margaret K Callahan, Michael A Postow, Naiyer A Rizvi, Alexander M Lesokhin, Neil H Segal, Charlotte E Ariyan, Ruth-Ann Gordon, Kathleen Reed,[...]. N Engl J Med 2013
16

Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF.
Michael Quigley, Florencia Pereyra, Björn Nilsson, Filippos Porichis, Catia Fonseca, Quentin Eichbaum, Boris Julg, Jonathan L Jesneck, Kathleen Brosnahan, Sabrina Imam,[...]. Nat Med 2010
335
16

Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients.
Julien Fourcade, Zhaojun Sun, Mourad Benallaoua, Philippe Guillaume, Immanuel F Luescher, Cindy Sander, John M Kirkwood, Vijay Kuchroo, Hassane M Zarour. J Exp Med 2010
876
16

Enhancing SIV-specific immunity in vivo by PD-1 blockade.
Vijayakumar Velu, Kehmia Titanji, Baogong Zhu, Sajid Husain, Annette Pladevega, Lilin Lai, Thomas H Vanderford, Lakshmi Chennareddi, Guido Silvestri, Gordon J Freeman,[...]. Nature 2009
579
16

Molecular and transcriptional basis of CD4⁺ T cell dysfunction during chronic infection.
Alison Crawford, Jill M Angelosanto, Charlly Kao, Travis A Doering, Pamela M Odorizzi, Burton E Barnett, E John Wherry. Immunity 2014
300
16

Molecular mechanisms of T cell co-stimulation and co-inhibition.
Lieping Chen, Dallas B Flies. Nat Rev Immunol 2013
16

Selective expansion of a subset of exhausted CD8 T cells by alphaPD-L1 blockade.
Shawn D Blackburn, Haina Shin, Gordon J Freeman, E John Wherry. Proc Natl Acad Sci U S A 2008
353
15

Progressive loss of memory T cell potential and commitment to exhaustion during chronic viral infection.
Jill M Angelosanto, Shawn D Blackburn, Alison Crawford, E John Wherry. J Virol 2012
165
14

PD-1 and its ligands in tolerance and immunity.
Mary E Keir, Manish J Butte, Gordon J Freeman, Arlene H Sharpe. Annu Rev Immunol 2008
14

Transcription factor T-bet represses expression of the inhibitory receptor PD-1 and sustains virus-specific CD8+ T cell responses during chronic infection.
Charlly Kao, Kenneth J Oestreich, Michael A Paley, Alison Crawford, Jill M Angelosanto, Mohammed-Alkhatim A Ali, Andrew M Intlekofer, Jeremy M Boss, Steven L Reiner, Amy S Weinmann,[...]. Nat Immunol 2011
330
14

Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity.
Rachel H McMahan, Lucy Golden-Mason, Michael I Nishimura, Brian J McMahon, Michael Kemper, Todd M Allen, David R Gretch, Hugo R Rosen. J Clin Invest 2010
244
13

Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.
Julie R Brahmer, Scott S Tykodi, Laura Q M Chow, Wen-Jen Hwu, Suzanne L Topalian, Patrick Hwu, Charles G Drake, Luis H Camacho, John Kauh, Kunle Odunsi,[...]. N Engl J Med 2012
13

Improved survival with ipilimumab in patients with metastatic melanoma.
F Stephen Hodi, Steven J O'Day, David F McDermott, Robert W Weber, Jeffrey A Sosman, John B Haanen, Rene Gonzalez, Caroline Robert, Dirk Schadendorf, Jessica C Hassel,[...]. N Engl J Med 2010
13

A role for the transcriptional repressor Blimp-1 in CD8(+) T cell exhaustion during chronic viral infection.
Haina Shin, Shawn D Blackburn, Andrew M Intlekofer, Charlly Kao, Jill M Angelosanto, Steven L Reiner, E John Wherry. Immunity 2009
324
13

Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy.
Se Jin Im, Masao Hashimoto, Michael Y Gerner, Junghwa Lee, Haydn T Kissick, Matheus C Burger, Qiang Shan, J Scott Hale, Judong Lee, Tahseen H Nasti,[...]. Nature 2016
867
13

Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells.
Lucy Golden-Mason, Brent E Palmer, Nasim Kassam, Lisa Townshend-Bulson, Stephen Livingston, Brian J McMahon, Nicole Castelblanco, Vijay Kuchroo, David R Gretch, Hugo R Rosen. J Virol 2009
339
12

Persistent LCMV infection is controlled by blockade of type I interferon signaling.
John R Teijaro, Cherie Ng, Andrew M Lee, Brian M Sullivan, Kathleen C F Sheehan, Megan Welch, Robert D Schreiber, Juan Carlos de la Torre, Michael B A Oldstone. Science 2013
517
12

Blockade of chronic type I interferon signaling to control persistent LCMV infection.
Elizabeth B Wilson, Douglas H Yamada, Heidi Elsaesser, Jonathan Herskovitz, Jane Deng, Genhong Cheng, Bruce J Aronow, Christopher L Karp, David G Brooks. Science 2013
496
12

Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma.
Omid Hamid, Caroline Robert, Adil Daud, F Stephen Hodi, Wen-Jen Hwu, Richard Kefford, Jedd D Wolchok, Peter Hersey, Richard W Joseph, Jeffrey S Weber,[...]. N Engl J Med 2013
12

PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells.
Erin E West, Hyun-Tak Jin, Ata-Ur Rasheed, Pablo Penaloza-Macmaster, Sang-Jun Ha, Wendy G Tan, Ben Youngblood, Gordon J Freeman, Kendall A Smith, Rafi Ahmed. J Clin Invest 2013
185
12

Interleukin-10 determines viral clearance or persistence in vivo.
David G Brooks, Matthew J Trifilo, Kurt H Edelmann, Luc Teyton, Dorian B McGavern, Michael B A Oldstone. Nat Med 2006
693
12

Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection.
Carolina Boni, Paola Fisicaro, Caterina Valdatta, Barbara Amadei, Paola Di Vincenzo, Tiziana Giuberti, Diletta Laccabue, Alessandro Zerbini, Albertina Cavalli, Gabriele Missale,[...]. J Virol 2007
646
12

Inhibitory Receptors Beyond T Cell Exhaustion.
Silvia A Fuertes Marraco, Natalie J Neubert, Grégory Verdeil, Daniel E Speiser. Front Immunol 2015
142
12

Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8(+) T cells.
Ben Youngblood, Kenneth J Oestreich, Sang-Jun Ha, Jaikumar Duraiswamy, Rama S Akondy, Erin E West, Zhengyu Wei, Peiyuan Lu, James W Austin, James L Riley,[...]. Immunity 2011
275
11

Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction.
Lydie Trautmann, Loury Janbazian, Nicolas Chomont, Elias A Said, Sylvain Gimmig, Benoit Bessette, Mohamed-Rachid Boulassel, Eric Delwart, Homero Sepulveda, Robert S Balderas,[...]. Nat Med 2006
11

T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion.
Daniel T Utzschneider, Amandine Legat, Silvia A Fuertes Marraco, Lucie Carrié, Immanuel Luescher, Daniel E Speiser, Dietmar Zehn. Nat Immunol 2013
176
11


Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma.
Tyler R Simpson, Fubin Li, Welby Montalvo-Ortiz, Manuel A Sepulveda, Katharina Bergerhoff, Frederick Arce, Claire Roddie, Jake Y Henry, Hideo Yagita, Jedd D Wolchok,[...]. J Exp Med 2013
938
11


Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade.
Yoshiko Iwai, Masayoshi Ishida, Yoshimasa Tanaka, Taku Okazaki, Tasuku Honjo, Nagahiro Minato. Proc Natl Acad Sci U S A 2002
11

Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired.
Mojgan Ahmadzadeh, Laura A Johnson, Bianca Heemskerk, John R Wunderlich, Mark E Dudley, Donald E White, Steven A Rosenberg. Blood 2009
11

The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity.
Chen Zhu, Ana C Anderson, Anna Schubart, Huabao Xiong, Jaime Imitola, Samia J Khoury, Xin Xiao Zheng, Terry B Strom, Vijay K Kuchroo. Nat Immunol 2005
11

The transcription factor FoxO1 sustains expression of the inhibitory receptor PD-1 and survival of antiviral CD8(+) T cells during chronic infection.
Matthew M Staron, Simon M Gray, Heather D Marshall, Ian A Parish, Jonathan H Chen, Curtis J Perry, Guoliang Cui, Ming O Li, Susan M Kaech. Immunity 2014
218
11

Overcoming T cell exhaustion in infection and cancer.
Kristen E Pauken, E John Wherry. Trends Immunol 2015
604
11


Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape.
Seng-Ryong Woo, Meghan E Turnis, Monica V Goldberg, Jaishree Bankoti, Mark Selby, Christopher J Nirschl, Matthew L Bettini, David M Gravano, Peter Vogel, Chih Long Liu,[...]. Cancer Res 2012
939
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.